TABLE 5.
Regions identified by both rare and all variants analysis in a particular population after Bonferroni adjustment.
| Population | Chro | Regions | Gene | Rare variants analysis | All variants analysis | ||||
| p-value in this population | Fisher’s p-value | # of SNPs in region | p-value in this population | Fisher’s p-value | #of SNPs in region | ||||
| Illumina | 1 | 21,069,170–21,113,181 | HP1BP3 | 7.97 × 10–11 | 3.65 × 10–8 | 224 | 8.03 × 10–11 | 2.54 × 10–7 | 296 |
| 3 | 48,445,260−48,471,460 | PLXNB1 | 5.82 × 10–8 | 7.17 × 10–6 | 155 | 5.82 × 10–8 | 1.43 × 10–5 | 187 | |
| 3 | 49,506,135–49,573,051 | DAG1 | 5.80 × 10–11 | 3.83 × 10–7 | 169 | 5.99 × 10–8 | 6.37 × 10–5 | 304 | |
| 17 | 5,015,229–5,017,677 | LOC101928000 | 1.20 × 10–6 | 4.25 × 10–5 | 78 | 1.14 × 10–6 | 1.72 × 10–4 | 119 | |
| 17 | 5,019,732–5,078,326 | USP6 | 3.11 × 10–7 | 1.31 × 10–4 | 253 | 2.92 × 10–7 | 3.43 × 10–5 | 406 | |
| Human Core | 12 | 56,512,003–56,516,280 | ZC3H10 | 9.95 × 10–7 | 1.37 × 10–4 | 54 | 1.05 × 10–6 | 1.16 × 10–4 | 71 |
| 12 | 56,521,985–56,538,460 | ESYT1 | 1.14 × 10–6 | 1.68 × 10–4 | 102 | 1.16 × 10–6 | 1.66 × 10–4 | 122 | |
| 12 | 56,546,203–56,551,771 | MYL6B | 6.04 × 10–7 | 7.77 × 10–5 | 61 | 6.04 × 10–7 | 9.85 × 10–5 | 76 | |
| 12 | 56,660,641–56,664,750 | COQ10A | 5.68 × 10–7 | 9.10 × 10–5 | 27 | 1.38 × 10–6 | 5.74 × 10–4 | 53 | |
| 12 | 57,623,355–57,628,718 | SHMT2 | 1.57 × 10–7 | 2.49 × 10–5 | 70 | 1.57 × 10–7 | 2.49 × 10–5 | 86 | |
| 12 | 57,628,685–57,634,475 | NDUFA4L2 | 1.90 × 10–7 | 2.81 × 10–5 | 52 | 1.90 × 10–7 | 2.81 × 10–5 | 66 | |
| 12 | 57,637,237–57,644,976 | STAC3 | 7.88 × 10–8 | 1.23 × 10–5 | 55 | 7.88 × 10–8 | 1.23 × 10–5 | 70 | |
| 12 | 57,647,546–57,824,788 | R3HDM2 | 1.96 × 10–7 | 1.10 × 10–5 | 501 | 1.96 × 10–7 | 1.11 × 10–5 | 729 | |
| 12 | 57,828,467–57,845,845 | INHBC | 1.06 × 10–6 | 2.94 × 10–5 | 85 | 1.06 × 10–6 | 2.94 × 10–5 | 133 | |